Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value: $204M (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 51.1%

Value $104M Shares 6,068,125 Est. Cost $40.43 Unrealized -62.8%

— Verona Pharma plc (VRNA) 11.6%

Value $23.58M Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 10.5%

Value $21.45M Shares 1,025,000 Est. Cost $10.24 Unrealized +103.3%

BMEA Biomea Fusion Inc (BMEA) 8.6%

Value $17.53M Shares 798,757 Est. Cost $17.65 Unrealized +77.3%

GLUE Monte Rosa Therapeutics Inc (GLUE) 4.9%

Value $10.09M Shares 1,472,331 Est. Cost $20.37 Unrealized -68.2%

— Reneo Pharmaceuticals Inc (RPHM) 2.8%

Value $5.813M Shares 886,075 Est. Cost $9.33 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 2.2%

Value $4.574M Shares 2,541,009 Est. Cost $11.18 Unrealized -84.8%

ACRS Aclaris Theraputics Inc (ACRS) 2.2%

Value $4.505M Shares 434,455 Est. Cost $10.31 Unrealized -12.2%

— Elevation Oncology Inc (ELEV) 2.1%

Value $4.309M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.3%

Value $2.592M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 0.9%

Value $1.836M Shares 1,043,267 Est. Cost $8.87 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.5%

Value $974K Shares 314,286 Est. Cost $1.74 Unrealized 0.0%

— Avrobio, Inc. (AVRO) 0.5%

Value $959K Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 0.4%

Value $762K Shares 1,691,151 Est. Cost $8.00 Unrealized —

— Viracta Therapeutics Inc (VIRX) 0.2%

Value $407K Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.2%

Value $380K Shares 387,653 Est. Cost $18.84 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$104M	51.1%	$40.43	-62.8%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$23.58M	11.6%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$21.45M	10.5%	$10.24	+103.3%	COM	87164F105
BMEA	Biomea Fusion Inc (BMEA)	798,757	$17.53M	8.6%	$17.65	+77.3%	COM	09077A106
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$10.09M	4.9%	$20.37	-68.2%	COM	61225M102
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$5.813M	2.8%	$9.33	—	COM	75974E103
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$4.574M	2.2%	$11.18	-84.8%	COM CL A	67080N101
ACRS	Aclaris Theraputics Inc (ACRS)	434,455	$4.505M	2.2%	$10.31	-12.2%	COM	00461U105
—	Elevation Oncology Inc (ELEV)	2,834,910	$4.309M	2.1%	$13.57	—	COM	28623U101
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2.592M	1.3%	$24.31	—	COM	85209E109
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$1.836M	0.9%	$8.87	—	COM	73730P108
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$974K	0.5%	$1.74	0.0%	COM	57055L206
—	Avrobio, Inc. (AVRO)	1,009,779	$959K	0.5%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc (AGLE)	1,691,151	$762K	0.4%	$8.00	—	COM	00773J103
—	Viracta Therapeutics Inc (VIRX)	288,571	$407K	0.2%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$380K	0.2%	$18.84	—	CL A COM	04965G109